Development and internal validation of a steatosis index in primary biliary cholangitis: a retrospective single-center study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Hepatic steatosis may coexist with primary biliary cholangitis (PBC), but PBC-related biochemical and lipid abnormalities may complicate its identification using laboratory-based indices. We aimed to develop and internally validate a PBC-specific steatosis index (PSI) using routinely collected variables. This retrospective single-center study included adults with biopsy-confirmed PBC during 2016–2025; hepatic steatosis was defined histologically as involvement of at least 5% of hepatocytes. Missing predictors were multiply imputed within training partitions. A genetic-algorithm formula-search procedure was evaluated by repeated nested five-fold cross-validation against least absolute shrinkage and selection operator (LASSO), a prespecified clinical model, and six conventional indices. Among 681 participants, 98 (14.4%) had histological steatosis. The locked two-variable PSI formula was 5 × triglycerides − 2 × diabetes status (1 = recorded diabetes; 0 = no recorded diabetes). The PSI procedure achieved an out-of-fold AUC of 0.703 (95% CI, 0.646–0.757), Brier score of 0.116, and calibration slope of 1.276. At the exploratory OOF probability cutoff of 0.131, sensitivity was 72.4%, specificity 59.3%, positive predictive value 23.1%, and negative predictive value 92.8%. PSI outperformed HSI and TyG-BMI after multiplicity adjustment but did not demonstrate superiority over TyG or LASSO. In this biopsy-confirmed PBC cohort, the PSI procedure showed moderate internally assessed discrimination for steatosis. The transparent and readily reproducible two-variable formula may help prioritize patients for further steatosis assessment when imaging-based evaluation is not readily available, but requires independent external validation before clinical implementation.
Source: BMC Gastroenterology
Language: English
Topic: Liver Diseases and Immunity
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W7236736197
